FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donna Reece

Research Profile

Disorders

Procedures

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Brian J Minnema; Mehul Patel; Donna Reece; Joseph Brandwein; Seyed Mohammedmehdi Hosseini-Mogaddam; Shahid Husain; Jeffrey H Lipton; Tony Mazzulli; Coleman Rotstein
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study.
Vishal Kukreti; Esther Masih-Khan; Suzanne Trudel; Trieu Young; Christine Chen; Chia-Min Chu; Haiyun Jiang; Victor Jimenez-Zepeda; Donna Reece
Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.
A Keith Stewart; Jonathan Sussman; Kirsty A Tompkins; Suzanne Trudel; Darrell White; Nizar J Bahlis; Andrew Belch; Michael Brundage; Guy Cantin; Judy-Anne W Chapman; Erica L Harnett; Michael J Kovacs; Martha Q Lacy; Deb C Marcellus; Donna Reece; Tony Reiman; Jean Roy; Morel Rubinger; Waleed Sabry; Lois Shepherd; Chaim Shustik; Kevin Song; Ralph M Meyer
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donna Reece (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian J Minnema; Mehul Patel; Donna Reece; Joseph Brandwein; Seyed Mohammedmehdi Hosseini-Mogaddam; Shahid Husain; Jeffrey H Lipton; Tony Mazzulli; Coleman Rotstein
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study.
Leukemia & lymphoma 2013;54(6):1250-5.
2013: Vishal Kukreti; Esther Masih-Khan; Suzanne Trudel; Trieu Young; Christine Chen; Chia-Min Chu; Haiyun Jiang; Victor Jimenez-Zepeda; Donna Reece
Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.
American journal of hematology 2013;88(4):337-8.
2013: A Keith Stewart; Jonathan Sussman; Kirsty A Tompkins; Suzanne Trudel; Darrell White; Nizar J Bahlis; Andrew Belch; Michael Brundage; Guy Cantin; Judy-Anne W Chapman; Erica L Harnett; Michael J Kovacs; Martha Q Lacy; Deb C Marcellus; Donna Reece; Tony Reiman; Jean Roy; Morel Rubinger; Waleed Sabry; Lois Shepherd; Chaim Shustik; Kevin Song; Ralph M Meyer
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial.
Blood 2013;121(9):1517-23.
2012: R L Comenzo; A Dispenzieri; R Falk; M Gertz; R A Kyle; H Landau; G Palladini; Donna Reece; Vaishali Sanchorawala; D Seldin; M Skinner; A Solomon; H Streicher; Ashutosh Wechalekar; K Wells; Jeffrey A Zonder; G Merlini
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.
Leukemia 2012;26(11):2317-25.
2012: Victor H Jimenez-Zepeda; Vishal Kukreti; Esther Masih-Khan; Joseph Mikhael; Christine Chen; Norman Franke; Suzanne Trudel; Andrew Winter; Donna Reece
Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(5):773-9.
2012: Allan Jiang; Donna Reece; Hong Chang
Genomic stratification of multiple myeloma treated with novel agents.
Leukemia & lymphoma 2012;53(2):202-7.
2012: Donna Reece; Michael Sebag; Kevin Song; C Tom Kouroukis; Richard Leblanc; John Ashkenas
Practical approaches to the use of lenalidomide in multiple myeloma: a canadian consensus.
Advances in hematology 2012;2012():621958.
2011: Nan Jiang; Connie Qi; Donna Reece; Young Trieu; Hong Chang
Genomic aberrations and survival of patients with light-chain-only multiple myeloma undergoing autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1790-5.
2011: Hong Chang; Young Trieu; Xiaoying Qi; Nan N Jiang; Wei Xu; Donna Reece
Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains.
Leukemia research 2011;35(1):95-8.
2011: Donna Reece; Dan Sullivan; Sagar Lonial; Ann F Mohrbacher; Gurkamal Chatta; Chaim Shustik; Howard Burris; Karthik Venkatakrishnan; Rachel Neuwirth; William J Riordan; Michael Karol; Lisa L Von Moltke; Milin Acharya; Peter Zannikos; A Keith Stewart
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma.
Cancer chemotherapy and pharmacology 2011;67(1):57-67.
2010: Donna Reece; David H Vesole; Smriti Shrestha; Mei-Jie Zhang; Waleska S Pérez; Angela Dispenzieri; Gustavo A Milone; Muneer H Abidi; Harold Atkins; Asad Bashey; Christopher N Bredeson; Willem Bujan Boza; Cesar O Freytes; Robert Peter Gale; James L Gajewski; John Gibson; gregory alan hale; Shaji Kumar; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Santiago Pavlovsky; Vivek Roy; Daniel J Weisdorf; Peter H Wiernik; Parameswaran N Hari
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.
Clinical lymphoma, myeloma & leukemia 2010;10(6):458-63.
2010: Hong Chang; Allan Jiang; Connie Qi; Young Trieu; Christine Chen; Donna Reece
Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
Leukemia & lymphoma 2010;51(11):2084-91.
2010: David Telio; Denis Bailey; Christine Chen; Michael Crump; Donna Reece; Vishal Kukreti
Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature.
American journal of hematology 2010;85(10):805-8.
2010: Hong Chang; Nan Jiang; Hua Jiang; Manujendra N Saha; Connie Qi; Wei Xu; Donna Reece
CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma.
Haematologica 2010;95(9):1542-7.
2010: Parameswaran Hari; Navneet S Majhail; Mei-Jie Zhang; Anna Hassebroek; Fareeha Siddiqui; Karen Ballen; Asad Bashey; Jenny Bird; Cesar O Freytes; John Gibson; Gregaory Hale; Leona Holmberg; Ram Kamble; Robert A Kyle; Hillard M Lazarus; Charles F LeMaistre; Fausto R Loberiza; Angelo Maiolino; Philip L McCarthy; Gustavo A Milone; Nancy Omondi; Donna Reece; Matthew Seftel; Michael E Trigg; David H Vesole; Brendan Weiss; Peter Wiernik; Stephanie J Lee; J Douglas Rizzo; Paulette Mehta
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):395-402.
2010: Hong Chang; Xiaoying Qi; A Jiang; Wei Xu; T Young; Donna Reece
1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Bone marrow transplantation 2010;45(1):117-21.
2009: Donna Reece; Vaishali Sanchorawala; Ute Hegenbart; Giampaolo Merlini; Giovanni Palladini; Jean-Paul Fermand; Robert A Vescio; Xiangyang Liu; Yusri A Elsayed; Andrew Cakana; Raymond L Comenzo
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.
Blood 2009;114(8):1489-97.
2009: Parameswaran Hari; Mei-Jie Zhang; Vivek Roy; Waleska S Pérez; Asad Bashey; L Bik To; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Santiago Pavlovsky; Donna Reece; Gary Schiller; J Vela-Ojeda; Daniel Weisdorf; David H Vesole
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.
Leukemia 2009;23(8):1528-34.
2009: Craig B Reeder; Donna Reece; V Kukreti; C Chen; Suzanne Trudel; J Hentz; B Noble; N A Pirooz; J E Spong; J G Piza; V H J Zepeda; J R Mikhael; J F Leis; P Leif Bergsagel; Rafael Fonseca; A Keith Stewart
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.
Leukemia 2009;23(7):1337-41.
2009: Parneet K Cheema; Sahar Zadeh; Vishal Kukreti; Donna Reece; Christine Chen; Suzanne Trudel; Joseph Mikhael
Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):686-93.
2009: Hong Chang; Connie Qi; Young Trieu; Allan Jiang; Ken H Young; Alden Chesney; Prashant Jani; Chen Wang; Donna Reece; Christine Chen
Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
Clinical lymphoma & myeloma 2009;9(1):36-8.
2009: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Anthony Boral; Dixie Esseltine; Patrick Y Wen; Anthony A Amato; Kenneth C Anderson; Jesus San Miguel
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
British journal of haematology 2009;144(6):895-903.
2009: M A Trinkaus; Stephen E Lapinsky; Michael Crump; Armand Keating; Donna Reece; C Chen; David Hallett; N Franke; A Winter; J R Mikhael
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.
Bone marrow transplantation 2009;43(5):411-5.
2009: Hong Chang; Xiaoying Qi; Joanna Yeung; Donna Reece; Wei Xu; Bruce Patterson
Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
Leukemia research 2009;33(2):259-62.
2008: Donna Reece; Giovanni Piza Rodriguez; Christine Chen; Suzanne Trudel; Vishal Kukreti; Joseph Mikhael; Mariela Pantoja; Wei Xu; A Keith Stewart
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4777-83.
2008: Shaji Kumar; Waleska S Pérez; Mei-Jie Zhang; Karen Ballen; Asad Bashey; L Bik To; Christopher N Bredeson; Mitchell S Cairo; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Martha Q Lacy; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Jan S Moreb; Santiago Pavlovsky; Donna Reece; David H Vesole; Peter H Wiernik; Parameswaran Hari
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1134-40.
2008: Asad Bashey; Waleska S Pérez; Mei-Jie Zhang; Kenneth C Anderson; Karen Ballen; James R Berenson; L Bik To; Rafael Fonseca; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio Giralt; Robert A Kyle; Hillard M Lazarus; Dipnarine Maharaj; Philip L McCarthy; Gustavo A Milone; Stephen D Nimer; Santiago Pavlovsky; Donna Reece; Gary Schiller; David H Vesole; Parameswaran Hari
Comparison of twin and autologous transplants for multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1118-24.
2008: Donna Reece; Heather A Leitch; Harold Atkins; Michael Voralia; Leah A Canning; Richard LeBlanc; Andrew R Belch; Darrell White; Michael J Kovacs
Treatment of relapsed and refractory myeloma.
Leukemia & lymphoma 2008;49(8):1470-85.
2007: F Jadu; L Lee; Michael Pharoah; Donna Reece; L Wang
A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):2015-9.
2007: Paul G Richardson; Pieter Sonneveld; Michael Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesus San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Melissa Alsina; S Vincent Rajkumar; Martha Lacy; Andrzej J Jakubowiak; William Dalton; Anthony Boral; Dixie Esseltine; David P Schenkein; Kenneth C Anderson
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
Blood 2007;110(10):3557-60.
2007: Donna Reece
Management of multiple myeloma: the changing landscape.
Blood reviews 2007;21(6):301-14.
2007: A Keith Stewart; Hong Chang; Suzanne Trudel; Kenneth C Anderson; Paul G Richardson; M Alsina; Donna Reece; S Young; A Sable-Hunt; Z Li; Jonathan J Keats; Scott A Van Wier; Gregory J Ahmann; Tammy Price-Troska; K Giusti; P Leif Bergsagel; Marta Chesi; Rafael Fonseca
Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.
Leukemia 2007;21(11):2358-9.
2007: Hong Chang; Young Trieu; Xiaoying Qi; Wei Xu; Keith A Stewart; Donna Reece
Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma.
Leukemia research 2007;31(6):779-82.
2007: Suzanne Trudel; A Keith Stewart; Zhihua Li; Yanjun Shu; Sheng-Ben Liang; Young Trieu; Donna Reece; Josh Paterson; Dingyan Wang; Xiao-Yan Wen
The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):621-9.
2006: Hong Chang; Xiaoying Qi; Young Trieu; Wei Xu; Jocelyn C Reader; Yi Ning; Donna Reece
Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation.
British journal of haematology 2006;135(4):486-91.
2006: Michael J Kovacs; Donna Reece; Deborah Marcellus; Ralph M Meyer; Sarah Mathews; Rui-Ping Dong; Elizabeth Eisenhauer
A phase II study of ZD6474 (Zactima, a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma--NCIC CTG IND.145.
Investigational new drugs 2006;24(6):529-35.
2006: Athanasios Anagnostopoulos; Parameswaran Hari; Waleska S Pérez; Karen K Ballen; Asad Bashey; Christopher N Bredeson; Cesar O Freytes; Robert Peter Gale; Morie A Gertz; John Gibson; Hartmut Goldschmidt; Hillard M Lazarus; Philip L McCarthy; Donna Reece; David H Vesole; Sergio Giralt
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):845-54.
2006: David H Vesole; Waleska S Pérez; Marwan Akasheh; Christian Boudreau; Donna Reece; Christopher N Bredeson
High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.
Mayo Clinic proceedings. Mayo Clinic 2006;81(7):880-8.
2005: Young Trieu; Suzanne Trudel; Gregory R Pond; Joseph Mikhael; Wilfrid Jaksic; Donna Reece; Christine I Chen; A Keith Stewart
Weekly cyclophosphamide and alternate-day prednisone: an effective, convenient, and well-tolerated oral treatment for relapsed multiple myeloma after autologous stem cell transplantation.
Mayo Clinic proceedings. Mayo Clinic 2005;80(12):1578-82.
2005: Hong Chang; Xiao Ying Qi; Sara Samiee; Qi-Long Yi; C Chen; Suzanne Trudel; Joseph Mikhael; Donna Reece; A Keith Stewart
Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.
Bone marrow transplantation 2005;36(9):793-6.
2005: Wilfrid Jaksic; Suzanne Trudel; Hong Chang; Young Trieu; Xi Qi; Joseph Mikhael; Donna Reece; Christine Chen; A Keith Stewart
Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7069-73.
2005: Julye C Lavoie; Joseph Michael Connors; Gordon L Phillips; Donna Reece; Michael J Barnett; Donna L Forrest; Randy D Gascoyne; Donna E Hogge; Stephen H Nantel; John D Shepherd; Clayton A Smith; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Nicholas J Voss; Thomas J Nevill
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.
Blood 2005;106(4):1473-8.
2005: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesús F San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; William S Dalton; Anthony Boral; Dixie Esseltine; Jane B Porter; David P Schenkein; Kenneth C Anderson
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
The New England journal of medicine 2005;352(24):2487-98.
2005: Karen K Ballen; R King; Michael Carston; Craig Kollman; G Nelson; S Lim; Donna Reece; Sergio Giralt; David H Vesole
Outcome of unrelated transplants in patients with multiple myeloma.
Bone marrow transplantation 2005;35(7):675-81.
2005: Suzanne Trudel; Zhi Hua Li; Ellen Wei; Marion Wiesmann; Hong Chang; Christine Chen; Donna Reece; Carla Heise; A Keith Stewart
CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.
Blood 2005;105(7):2941-8.
2005: Ashutosh Wechalekar; Dominic Amato; Chris Chen; A Keith Stewart; Donna Reece
IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
Annals of hematology 2005;84(2):115-7.
2005: Hong Chang; Connie Qi; Qi-Long Yi; Donna Reece; A Keith Stewart
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation.
Blood 2005;105(1):358-60.
2004: John S Thompson; Claire Pomeroy; Richard J Kryscio; Stephen A Brown; Donna Reece; Rita Kramer; Dianna S Howard; Gary VanZant; Suzanne Humphries; Gordon Phillips
Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):858-66.
2004: Gordon L Phillips; Barry Meisenberg; Donna Reece; Val R Adams; Ashraf Badros; Janet Brunner; Robert G Fenton; Joanne Filicko; Dolores Grosso; gregory alan hale; Dianna S Howard; V P Johnson; AB Kniska; KW Marshall; R Nath; E Reed; Aaron P Rapoport; Naoko Takebe; David H Vesole; John L Wagner; Neal Flomenberg
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):473-83.
2004: Hong Chang; Stephen Sloan; Dan Li; Lihua Zhuang; Qi-Long Yi; Christine I Chen; Donna Reece; Kathy Chun; A Keith Stewart
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
British journal of haematology 2004;125(1):64-8.
2004: Gordon L Phillips; Barry Meisenberg; Donna Reece; Val R Adams; Ashraf Badros; J L Brunner; Robert G Fenton; Joanne Filicko; D L Grosso; gregory alan hale; Dianna S Howard; V P Johnson; AB Kniska; KW Marshall; Bijoyesh Mookerjee; R Nath; Aaron P Rapoport; Clarence Sarkodee-Adoo; Naoko Takebe; David H Vesole; John L Wagner; Neal Flomenberg
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Bone marrow transplantation 2004;33(8):781-7.
2004: P N Mollee; Ashutosh Wechalekar; Denise Pereira; N Franke; Donna Reece; C Chen; A Keith Stewart
Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
Bone marrow transplantation 2004;33(3):271-7.
2004: Hong Chang; Ashutosh Wechalekar; Linda Li; Donna Reece
Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin.
Cancer genetics and cytogenetics 2004;148(1):44-8.
2003: Donna Reece; Christopher N Bredeson; Waleska S Pérez; Sundar Jagannath; Mei-Jie Zhang; Karen K Ballen; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; Morie A Gertz; J Gibson; Sergio Giralt; Armand Keating; R A Kyle; D Maharaj; D Marcellus; Philip L McCarthy; Gustavo A Milone; Stephen D Nimer; Santiago Pavlovsky; L B To; Daniel J Weisdorf; Peter H Wiernik; J R Wingard; David H Vesole
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
Bone marrow transplantation 2003;32(12):1135-43.
2003: Donna Reece; Anna Sureda
High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin's lymphoma.
Cancer treatment reviews 2003;29(6):555-9.
2003: Ashutosh Wechalekar; Christine I Chen; D Sutton; Donna Reece; Michael Voralia; A Keith Stewart
Intermediate dose thalidomide (200 mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma.
Leukemia & lymphoma 2003;44(7):1147-9.
2003: Donna Reece; Kenneth A Foon; Malaya Bhattarcharya-Chatterjee; Doug Adkins; E Randolph Broun; D Gerald Connaghan; John F DiPersio; H Kent Holland; Dianna A Howard; gregory alan hale; Hans G Klingemann; Rita K Munn; Anatasios Raptis; Gordon L Phillips
Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.
Clinical breast cancer 2003;3 Suppl 4():S152-7.
2002: Donna Reece
Hematopoietic stem cell transplantation in Hodgkin disease.
Current opinion in oncology 2002;14(2):165-70.
2001: Donna Reece; Kenneth A Foon; M Battacharya-Chatterjee; D Adkins; E R Broun; D Gerald Connaghan; John F DiPersio; H Kent Holland; Dianna S Howard; gregory alan hale; Hans G Klingemann; Rita K Munn; Anatasios Raptis; Gordon L Phillips
Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.
Clinical breast cancer 2001;2(1):52-8.
2001: Hillard M Lazarus; Fausto R Loberiza; Mei-Jie Zhang; James O Armitage; Karen K Ballen; Asad Bashey; Brian J Bolwell; Linda J Burns; Cesar O Freytes; Robert Peter Gale; J Gibson; Roger H Herzig; Charles F LeMaistre; D Marks; J Mason; Alan Marshall Miller; Gustavo A Milone; Santiago Pavlovsky; Donna Reece; J Douglas Rizzo; Koen van Besien; Julie M Vose; Mary M Horowitz
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Bone marrow transplantation 2001;27(4):387-96.
2000: Donna Reece; Kenneth A Foon; Malaya Bhattacharya-Chatterjee; gregory alan hale; Dianna S Howard; Rita K Munn; R Nath; B A Plummer; A Teitelbaum; Gordon L Phillips
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer.
Bone marrow transplantation 2000;26(7):729-35.
2000: Donna Reece; DA Brockington; Gordon L Phillips; Michael J Barnett; Hans G Klingemann; Stephen H Nantel; Heather J Sutherland; John D Shepherd
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Bone marrow transplantation 2000;26(6):621-6.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Michael J Barnett
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(6):605-12.
2000: gregory alan hale; Donna Reece; Rita K Munn; AB Kniska; Gordon L Phillips
Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis.
Bone marrow transplantation 2000;25(4):449-51.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Eibhlin Conneally; Michael J Barnett
Allografting for indolent lymphoid neoplasms.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():59-61.
1999: Dianna S Howard; G L Phillips II; Donna Reece; Rita K Munn; J Henslee-Downey; MQ Pittard; M Barker; Claire Pomeroy
Adenovirus infections in hematopoietic stem cell transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1494-501.
1999: Gordon L Phillips; D D Davey; gregory alan hale; KW Marshall; Rita K Munn; R Nath; Donna Reece; Gary Van Zant
Granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantation.
Leukemia & lymphoma 1999;35(3-4):303-9.
1999: Donna Reece; Thomas J Nevill; A Sayegh; John Spinelli; DA Brockington; Michael J Barnett; Hans G Klingemann; Joseph Michael Connors; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Randall Fairey; Susan E O'Reilly; Gordon L Phillips
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease.
Bone marrow transplantation 1999;23(11):1131-8.
1999: Hillard M Lazarus; Philip Rowlings; Mei-Jie Zhang; Julie M Vose; James O Armitage; P J Bierman; James L Gajewski; Robert Peter Gale; Armand Keating; John P Klein; Carole B Miller; Gordon L Phillips; Donna Reece; Kathleen A Sobocinski; Koen van Besien; Mary M Horowitz
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):534-45.
1998: S R Jackson; Martin Tweeddale; Michael J Barnett; John Spinelli; Heather J Sutherland; Donna Reece; Hans G Klingemann; Stephen H Nantel; Henry Fung; Cynthia L Toze; Gordon L Phillips; John D Shepherd
Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
Bone marrow transplantation 1998;21(7):697-704.
1998: Omer N Koç; Stanton L Gerson; Gordon L Phillips; Brenda W Cooper; LA Kutteh; Gary Van Zant; Donna Reece; Robert M Fox; Jane E Schupp; N Tainer; Hillard M Lazarus
Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Bone marrow transplantation 1998;21(4):337-43.
1997: Steven H Bernstein; C J Eaves; Roger H Herzig; Joseph Fay; J Lynch; Gordon L Phillips; Neal Christiansen; Donna Reece; Solveig G Ericson; M Stephan; M Kovalsky; K Hawkins; H Rasmussen; A Devos; Geoffrey P Herzig
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer.
British journal of haematology 1997;99(4):888-95.
1997: Gordon L Phillips; Donna Reece; Steven Neil Wolff; J H Goldie
The use of conventional salvage chemotherapy before dose-intensive cytotoxic therapy and autologous transplantation for aggressive-histology lymphoma: a case for re-evaluation.
Leukemia & lymphoma 1997;26(5-6):507-13.
1997: Bakul I Dalal; V Wu; Michael J Barnett; Douglas E Horsman; John Spinelli; Sheldon C Naiman; John D Shepherd; Stephen H Nantel; Donna Reece; Heather J Sutherland; Hans G Klingemann; Gordon L Phillips
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts.
Leukemia & lymphoma 1997;26(3-4):299-306.
1996: Donna Reece; Gordon L Phillips
Intensive therapy and autologous stem cell transplantation for Hodgkin's disease in first relapse after combination chemotherapy.
Leukemia & lymphoma 1996;21(3-4):245-53.
1995: Henry Fung; John D Shepherd; Sheldon C Naiman; Michael J Barnett; Donna Reece; Douglas E Horsman; Stephen H Nantel; Heather J Sutherland; John Spinelli; Hans G Klingemann
Acute monocytic leukemia: a single institution experience.
Leukemia & lymphoma 1995;19(3-4):259-65.
1995: Donna Reece; Michael J Barnett; John D Shepherd; Donna E Hogge; R J Klasa; Stephen H Nantel; Heather J Sutherland; Hans G Klingemann; Randall Fairey; N J Voss
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Blood 1995;86(2):451-6.
1995: R J Cuthbert; John D Shepherd; Stephen H Nantel; Michael J Barnett; Donna Reece; Hans G Klingemann; K W Chan; John Spinelli; Heather J Sutherland; Gordon L Phillips
Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Clinical and investigative medicine. Médecine clinique et experimentale 1995;18(2):122-30.
1995: H Tezcan; Michael J Barnett; C N Bredeson; Donna Reece; John D Shepherd; Bakul I Dalal; Douglas E Horsman; Hans G Klingemann; Stephen H Nantel; John Spinelli
Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992.
Leukemia & lymphoma 1995;16(5-6):439-44.
1995: Donna Reece; John D Shepherd; Hans G Klingemann; Heather J Sutherland; Stephen H Nantel; Michael J Barnett; John Spinelli; Gordon L Phillips
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation.
Bone marrow transplantation 1995;15(1):117-23.
1994: Donna Reece; Gordon L Phillips
Intensive therapy and autotransplantation in Hodgkin's disease.
Stem cells (Dayton, Ohio) 1994;12(5):477-93.
1994: S A Rayani; C J Nimmo; Luciana Frighetto; S M Martinusen; D M Nickoloff; Donna Reece; Peter J Jewesson
Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.
The Annals of pharmacotherapy 1994;28(7-8):852-6.
1994: Donna Reece; Joseph Michael Connors; John Spinelli; Michael J Barnett; Randall Fairey; Hans G Klingemann; Stephen H Nantel; S O'Reilly; John D Shepherd; Heather J Sutherland
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.
Blood 1994;83(5):1193-9.
1994: H G Klingemann; John D Shepherd; Donna Reece; M J Barnett; Stephen H Nantel; Heather J Sutherland; John Spinelli; G L Phillips
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Bone marrow transplantation 1994;14 Suppl 4():S14-8.
1994: H G Klingemann; K Wilkie-Boyd; A Rubin; N Onetto; Stephen H Nantel; M J Barnett; Donna Reece; John D Shepherd; G L Phillips
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
Biotechnology therapeutics 1994;5(1-2):1-13.
1993: John D Shepherd; Michael J Barnett; Joseph Michael Connors; John Spinelli; Heather J Sutherland; H G Kingemann; Stephen H Nantel; Donna Reece; C J Currie; Gordon L Phillips
Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma.
Bone marrow transplantation 1993;12(6):591-6.
1993: Michael J Barnett; C J Eaves; Gordon L Phillips; Donna E Hogge; Hans G Klingemann; P M Lansdorp; Stephen H Nantel; Donna Reece; John D Shepherd; Heather J Sutherland
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():64-6.
1993: Michael J Barnett; C M Coppin; N Murray; Thomas J Nevill; Donna Reece; Hans G Klingemann; John D Shepherd; Stephen H Nantel; Heather J Sutherland; Gordon L Phillips
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
British journal of cancer 1993;68(3):594-8.
1993: John D Shepherd; Donna Reece; Michael J Barnett; Hans G Klingemann; Stephen H Nantel; Heather J Sutherland; Gordon L Phillips
Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide.
Leukemia & lymphoma 1993;9(3):211-5.
1993: Donna Reece; Michael J Barnett; Joseph Michael Connors; Hans G Klingemann; Susan E O'Reilly; John D Shepherd; Heather J Sutherland; Gordon L Phillips
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Bone marrow transplantation 1993;11(2):139-46.
1993: L Embree; R B Burns; J R Heggie; Gordon L Phillips; Donna Reece; John Spinelli; D O Hartley; Norma Hudon; J H Goldie
Gas-chromatographic analysis of busulfan for therapeutic drug monitoring.
Cancer chemotherapy and pharmacology 1993;32(2):137-42.
1993: Donna Reece; M B Elmongy; Michael J Barnett; Hans G Klingemann; John D Shepherd; Gordon L Phillips
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemias.
Cancer investigation 1993;11(5):509-16.
1992: R J Cuthbert; Gordon L Phillips; Michael J Barnett; Stephen H Nantel; Donna Reece; John D Shepherd; Hans G Klingemann
Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.
Bone marrow transplantation 1992;10(5):451-5.
1992: Thomas J Nevill; John D Shepherd; Donna Reece; Michael J Barnett; Stephen H Nantel; Hans G Klingemann; Gordon L Phillips
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT.
Bone marrow transplantation 1992;10(5):445-50.
1992: Michael J Barnett; C J Eaves; G L Phillips; Donna E Hogge; Hans G Klingemann; P M Lansdorp; Stephen H Nantel; Donna Reece; John D Shepherd; Heather J Sutherland
Autografting in chronic myeloid leukemia with cultured marrow.
Leukemia 1992;6 Suppl 4():118-9.
1992: Thomas J Nevill; M H Tirgan; H J Deeg; Hans G Klingemann; Donna Reece; John D Shepherd; Michael J Barnett; Gordon L Phillips
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.
Bone marrow transplantation 1992;9(5):349-54.
1992: Gordon L Phillips; Donna Reece; Joseph Michael Connors
Bone marrow transplantation in Hodgkin's disease.
Bone marrow transplantation 1992;10 Suppl 1():64-6.
1991: H G Klingemann; A P Grigg; K Wilkie-Boyd; M J Barnett; A C Eaves; Donna Reece; John D Shepherd; G L Phillips
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].
Blood 1991;78(12):3306-11.
1991: Gordon L Phillips; Michael J Barnett; M C Brain; K W Chan; L B Huebsch; Hans G Klingemann; Jacinta Meharchand; Donna Reece; W B Rybka; John D Shepherd
Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Bone marrow transplantation 1991;8(6):477-87.
1991: John D Shepherd; L E Pringle; Michael J Barnett; Hans G Klingemann; Donna Reece; Gordon L Phillips
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):2016-20.
1991: A Kureishi; Peter J Jewesson; Morel Rubinger; C D Cole; Donna Reece; G L Phillips; JA Smith; A W Chow
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
Antimicrobial agents and chemotherapy 1991;35(11):2246-52.
1991: Donna Reece; D A Frei-Lahr; John D Shepherd; K Dorovini-Zis; Randy D Gascoyne; D A Graeb; John Spinelli; Michael J Barnett; Hans G Klingemann; Geoffrey P Herzig
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.
Bone marrow transplantation 1991;8(5):393-401.
1991: Gordon L Phillips; John D Shepherd; Michael J Barnett; P M Lansdorp; Hans G Klingemann; John Spinelli; Thomas J Nevill; K W Chan; Donna Reece
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1880-8.
1991: Donna Reece; Michael J Barnett; Joseph Michael Connors; Randall Fairey; Joseph W Fay; John P Greer; Geoffrey P Herzig; Roger H Herzig; Hans G Klingemann; C F LeMaistre
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1871-9.
1991: Thomas J Nevill; Michael J Barnett; Hans G Klingemann; Donna Reece; John D Shepherd; Gordon L Phillips
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1224-32.
1991: A Lohri; M Barnett; Randall Fairey; Susan E O'Reilly; Gordon L Phillips; Donna Reece; N Voss; Joseph Michael Connors
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.
Blood 1991;77(10):2292-8.
1991: Gordon L Phillips; Donna Reece; John D Shepherd; Michael J Barnett; R A Brown; D A Frei-Lahr; Hans G Klingemann; B J Bolwell; John Spinelli; Roger H Herzig
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults.
Blood 1991;77(7):1429-35.
1991: Michael J Barnett; Heather J Sutherland; A C Eaves; Donna E Hogge; R K Humphries; Hans G Klingemann; P M Lansdorp; Gordon L Phillips; Donna Reece; John D Shepherd
Human hematopoietic stem cells in long-term culture: quantitation and manipulation.
Bone marrow transplantation 1991;7 Suppl 1():70.
1990: Hans G Klingemann; Michael J Barnett; Donna Reece; John D Shepherd; Gordon L Phillips
Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease.
Bone marrow transplantation 1990;6(3):199-202.
1990: Gordon L Phillips; Donna Reece; K G Lerner; J M Connors
Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.
Bone marrow transplantation 1990;6(1):45-7.
1990: H G Klingemann; A C Eaves; M J Barnett; Donna Reece; John D Shepherd; A R Belch; J M Brandwein; A Langleben; P A Koch; G L Phillips
Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
Clinical and investigative medicine. Médecine clinique et experimentale 1990;13(2):77-81.
1989: Stephen L Sacks; R J Wanklin; Donna Reece; K A Hicks; K L Tyler; D M Coen
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
Annals of internal medicine 1989;111(11):893-9.
1989: Gordon L Phillips; Donna Reece; Michael J Barnett; Joseph Michael Connors; Joseph W Fay; G P Herzig; R H Herzig; Hans G Klingemann; John D Shepherd; Steven Neil Wolff
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1039-45.
1988: John D Shepherd; T B Shore; Donna Reece; Michael J Barnett; Hans G Klingemann; N A Buskard; Gordon L Phillips
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
Bone marrow transplantation 1988;3(6):553-8.